We are live on
!
Find out more
KCM
Kornitzer Capital Management Portfolio holdings
AUM
$4.79B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+9.5%
1 Year Est. Return
+30.56%
3 Year Est. Return
+78.14%
5 Year Est. Return
+100.44%
10 Year Est. Return
+507.87%
AUM
$5.11B
AUM Growth
+$146M
(+2.9%)
Cap. Flow
-$216M
Cap. Flow
% of AUM
-4.22%
Top 10 Holdings %
Top 10 Hldgs %
13.47%
Holding
512
New
23
Increased
90
Reduced
264
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CLDR
Cloudera, Inc.
CLDR
|
+$29.8M |
| 2 |
DOCU
DocuSign
DOCU
|
+$22.2M |
| 3 |
Zimmer Biomet
ZBH
|
+$20.5M |
| 4 |
OPLN
Openlane
OPLN
|
+$16.9M |
| 5 |
Adaptive Biotechnologies
ADPT
|
+$15.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CarMax
KMX
|
+$21.4M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$19.7M |
| 3 |
Tradeweb Markets
TW
|
+$19.3M |
| 4 |
LVGO
Livongo Health, Inc. Common Stock
LVGO
|
+$17.8M |
| 5 |
MasTec
MTZ
|
+$16.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Healthcare | 19.46% |
| 3 | Industrials | 11.27% |
| 4 | Consumer Staples | 10.15% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
AstraZeneca
AZN
$245B
| $5.15M | 0.1% |
47,029
| – | – |
|
252
Sanofi
SNY
$104B
| $5M | 0.1% |
99,754
| – | – |
|
253
PayPal
PYPL
$49.9B
| $4.91M | 0.1% |
24,924
| – | – |
|
|
CERN
254
DELISTED
Cerner Corp
CERN
| $4.85M | 0.1% |
67,095
-384
| -0.6% | -$27.4K |
|
255
Phillips 66
PSX
$89.2B
| $4.76M | 0.09% |
91,798
-1,575
| -2% | -$96.1K |
|
256
CarGurus
CARG
$3.21B
| $4.73M | 0.09% |
218,490
-1,940
| -0.9% | -$49.7K |
|
257
Helmerich & Payne
HP
$4.25B
| $4.61M | 0.09% |
314,600
-24,320
| -7% | -$424K |
|
258
Acadia Pharmaceuticals
ACAD
$5.07B
| $4.55M | 0.09% |
110,260
-208,312
| -65% | -$9M |
|
259
Northern Trust
NTRS
$34.9B
| $4.36M | 0.09% |
55,900
-290
| -0.5% | -$23.3K |
|
260
Comcast
CMCSA
$89.8B
| $4.15M | 0.08% |
89,621
-1,772
| -2% | -$77K |
|
261
JPMorgan Chase
JPM
$970B
| $4.13M | 0.08% |
42,898
-750
| -2% | -$73.7K |
|
262
International Paper
IP
$21.7B
| $4.1M | 0.08% |
106,904
-11,959
| -10% | -$422K |
|
263
Delek Logistics
DKL
$3.15B
| $3.97M | 0.08% |
140,000
| – | – |
|
264
AB InBev
BUD
$156B
| $3.96M | 0.08% |
73,558
-6,525
| -8% | -$361K |
|
265
AbbVie
ABBV
$441B
| $3.89M | 0.08% |
44,419
+15,615
| +54% | +$1.47M |
|
266
Broadcom
AVGO
$2T
| $3.58M | 0.07% |
98,360
-2,360
| -2% | -$79K |
|
267
Steven Madden
SHOO
$3.49B
| $3.54M | 0.07% |
181,419
-1,817
| -1% | -$39.1K |
|
|
EA
268
DELISTED
Electronic Arts
EA
| $3.45M | 0.07% |
26,489
-6,521
| -20% | -$889K |
|
269
Boston Beer
SAM
$1.87B
| $3.45M | 0.07% |
3,904
-25
| -0.6% | -$19.7K |
|
270
Adobe
ADBE
$102B
| $3.45M | 0.07% |
7,028
-174
| -2% | -$80.9K |
|
271
MarketAxess Holdings
MKTX
$5.72B
| $3.25M | 0.06% |
6,755
-875
| -11% | -$433K |
|
|
CHCT
272
Community Healthcare Trust
CHCT
$426M
| $3.24M | 0.06% |
69,206
| – | – |
|
273
Intuit
INTU
$90.3B
| $3.16M | 0.06% |
9,675
-151
| -2% | -$47.2K |
|
274
Thermo Fisher Scientific
TMO
$222B
| $3.05M | 0.06% |
6,901
-169
| -2% | -$69.8K |
|
275
Newmont
NEM
$126B
| $3.04M | 0.06% |
47,830
+6,830
| +17% | +$445K |
|
Similar funds
MP
AC
RC
JCM
SAMU
BMO
SCA
Kornitzer Capital Management's Q3 2020 Portfolio in Review
As of Q3 2020, Kornitzer Capital Management held 512 positions worth $5.11B, up 2.9% from $4.96B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Kornitzer Capital Management withdrew a net $216M in Q3 2020, closing 24 positions and reducing 264 holdings. Its most notable exit was BioMarin Pharmaceuticals, an estimated $19.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Kornitzer Capital Management opened a new position in Cloudera, Inc. worth $28M.
- Kornitzer Capital Management's largest Q3 2020 buy was Cloudera, Inc.: 2,570,290 shares worth $28M.
- Kornitzer Capital Management added most to DocuSign in Q3 2020, an estimated $22.2M increase.
- Kornitzer Capital Management's biggest Q3 2020 reduction was CarMax, cutting an estimated $21.4M.
- Kornitzer Capital Management fully exited BioMarin Pharmaceuticals in Q3 2020, selling an estimated $19.7M.
- Kornitzer Capital Management's ten largest holdings make up 13% of its $5.11B portfolio in Q3 2020.
- Kornitzer Capital Management opened 23 new positions and closed 24 in Q3 2020.
- Kornitzer Capital Management's portfolio value rose 2.9% quarter-over-quarter to $5.11B.
Based on Kornitzer Capital Management's 13F filing for Q3 2020, filed 30 Oct 2020.